Authors:
Latchman, Y
Wood, CR
Chernova, T
Chaudhary, D
Borde, M
Chernova, I
Iwai, Y
Long, AJ
Brown, JA
Nunes, R
Greenfield, EA
Bourque, K
Boussiotis, VA
Carter, LL
Carreno, BM
Malenkovich, N
Nishimura, H
Okazaki, T
Honjo, T
Sharpe, AH
Freeman, GJ
Citation: Y. Latchman et al., PD-L2 is a second ligand for PD-I and inhibits T cell activation, NAT IMMUNOL, 2(3), 2001, pp. 261-268
Authors:
Carreno, BM
Bennett, F
Chau, TA
Ling, V
Luxenberg, D
Jussif, J
Baroja, ML
Madrenas, J
Citation: Bm. Carreno et al., CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression, J IMMUNOL, 165(3), 2000, pp. 1352-1356
Citation: Cpm. Broeren et al., Costimulation light: Activation of CD4(+) T cells with CD80 or CD86 ratherthan anti-CD28 leads to a Th2 cytokine profile, J IMMUNOL, 165(12), 2000, pp. 6908-6914
Authors:
Freeman, GJ
Long, AJ
Iwai, Y
Bourque, K
Chernova, T
Nishimura, H
Fitz, LJ
Malenkovich, N
Okazaki, T
Byrne, MC
Horton, HF
Fouser, L
Carter, L
Ling, V
Bowman, MR
Carreno, BM
Collins, M
Wood, CR
Honjo, T
Citation: Gj. Freeman et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation, J EXP MED, 192(7), 2000, pp. 1027-1034